Rhoel Dinglasan attended graduate school at Yale University, earning a MPH in Global Health with a concentration in Infectious Disease and the MPhil in Molecular Vector Biology (Dengue transmission/Wolbachia biology), before transferring to the Center for Vaccine Development at the University of Maryland, School of Medicine, to earn a PhD in Microbiology & Immunology, working in the laboratory of Prof. Abdu Azad on Anopheles mosquito glycobiology. He was a Dmitri V. d’Arbeloff (Millipore Foundation) and NIAID, NIH Ruth L. Kirschstein National Research Scholar Award postdoctoral fellow in the laboratory of Prof. Marcelo Jacobs-Lorena, a renowned expert on mosquito transgenesis and vector host-pathogen interactions at the Johns Hopkins Malaria Research Institute (JHMRI). He joined the Molecular Microbiology & Immunology/JHMRI faculty of Johns Hopkins University as a tenure-track Assistant Professor in early 2009 with a National Institute of Allergy & Infectious Diseases, US National Institutes of Health (NIH) K22 Career Development Award. Dinglasan’s research interests include mosquito biology & physiology, pathogenesis, and the application of mass spectrometry-based approaches toward the molecular and cellular analysis of critical transition steps during malaria parasite (human-mosquito-human) transmission. Importantly, his research program also leverages nanoparticle technology in the development of vaccine and drug delivery systems as well as diagnostics. He was recruited to the University of Florida in 2015 as part of the UF Preeminence Faculty Initiative and is currently an Associate Professor of Infectious Diseases (Tenured) at the UF Emerging Pathogens Institute and the Director of the CDC Southeastern Center of Excellence in Vector-Borne Diseases. His academic affiliations are with the Department of Infectious Diseases & Immunology at the UF College of Veterinary Medicine and the Department of Anatomy & Cell Biology at the UF College of Medicine. Dinglasan has served as Chair of the Enabling Technologies Consultancy Group for the Malaria Eradication Research Agenda (malERA). He currently serves on the Editorial Board of PLoS Neglected Tropical Diseases and the Advisory Board for the United States Military Malaria Vaccine Program.